E3 Ligase STUB1/CHIP Regulates NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Accumulation in Aged Brain, a Process Impaired in Certain Alzheimer Disease Patients

被引:49
|
作者
Tsvetkov, Peter [1 ]
Adamovich, Yaarit [1 ]
Elliott, Evan [2 ]
Shaul, Yosef [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
基金
以色列科学基金会;
关键词
HEAT-SHOCK PROTEINS; PROTEASOMAL DEGRADATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXIDATIVE STRESS; DT-DIAPHORASE; PHOSPHORYLATED TAU; CHIP; POLYMORPHISM; ASSOCIATION; P53;
D O I
10.1074/jbc.M110.193276
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NAD(P) H: quinone oxidoreductase 1 (NQO1) is a flavoenzyme that is important in maintaining the cellular redox state and regulating protein degradation. The NQO1 polymorphism C609T has been associated with increased susceptibility to various age-related pathologies. We show here that NQO1 protein level is regulated by the E3 ligase STUB1/CHIP (C terminus of Hsc70-interacting protein). NQO1 binds STUB1 via the Hsc70-interacting domain (tetratricopeptide repeat domain) and undergoes ubiquitination and degradation. We demonstrate here that the product of the C609T polymorphism (P187S) is a stronger STUB1 interactor with increased susceptibility to ubiquitination by the E3 ligase STUB1. Furthermore, age-dependent decrease of STUB1 correlates with increased NQO1 accumulation. Remarkably, examination of hippocampi from Alzheimer disease patients revealed that in half of the cases examined the NQO1 protein level was undetectable due to C609T polymorphism, suggesting that the age-dependent accumulation of NQO1 is impaired in certain Alzheimer disease patients.
引用
收藏
页码:8839 / 8845
页数:7
相关论文
共 50 条
  • [1] Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1)
    Megarity, Clare F.
    Benley, Hoda Abdel-Aal
    Caraher, M. Clare
    Scott, Katherine A.
    Whitehead, Roger C.
    Jowitt, Thomas A.
    Gutierrez, Aldo
    Bryce, Richard A.
    Nolan, Karen A.
    Stratford, Ian J.
    Timson, David J.
    CHEMBIOCHEM, 2019, 20 (22) : 2841 - 2849
  • [2] NAD(P)H:quinone oxidoreductase 1 (NQO1):: Role as a superoxide scavenger
    Siegel, D
    Gustafson, D
    Dehn, D
    Boonchoong, P
    Han, JY
    Berliner, L
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 : S14 - S14
  • [3] Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
    Sieger, D
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) : 246 - 253
  • [4] Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer
    Lewis, AM
    Ough, M
    Hinkhouse, MM
    Tsao, MS
    Oberley, LW
    Cullen, JJ
    MOLECULAR CARCINOGENESIS, 2005, 43 (04) : 215 - 224
  • [5] NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia
    Hori, H
    Ohmori, O
    Matsumoto, C
    Shinkai, T
    Nakamura, J
    PSYCHIATRY RESEARCH, 2003, 118 (03) : 235 - 239
  • [6] NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
    Zhang, Kuojun
    Chen, Dong
    Ma, Kun
    Wu, Xiaoxing
    Hao, Haiping
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 6983 - 7003
  • [7] NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in bioactivation
    Ross, D
    Siegel, D
    Dehn, DL
    Winski, SL
    DRUG METABOLISM REVIEWS, 2002, 34 : 20 - 20
  • [8] NAD(P)H: quinone oxidoreductase 1 (NQO1)- A viable biomarker in colorectal cancer
    Ganji, Chaithanya
    Lakkakula, Bhaskar V. K.
    Behera, Santosh Kumar
    El-Rayes, Bassel F.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
    Siegel, David
    Yan, Chao
    Ross, David
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 1033 - 1040
  • [10] A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): Relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity
    Ross, D
    Traver, RD
    Siegel, D
    Kuehl, BL
    Misra, V
    Rauth, AM
    BRITISH JOURNAL OF CANCER, 1996, 74 (06) : 995 - 996